Cheng Zeng (621718)

No ORCID on file · 7 papers in corpus · active 2024

Study types

  • dataset 7

Condition tags

  • endometriosis 7
dataset 2024
DataSheet1_Potential mechanism of Luoshi Neiyi prescription in endometriosis based on serum pharmacochemistry and network pharmacology.PDF
·doi:10.3389/fphar.2024.1395160.s001

IntroductionEndometriosis (EMs) is characterized by ectopic growth of active endometrial tissue outside the uterus. The Luoshi Neiyi prescription (LSNYP) has been extensively used for treating EMs in China. However, data on the active chemi…

dataset 2024
DataSheet2_Potential mechanism of Luoshi Neiyi prescription in endometriosis based on serum pharmacochemistry and network pharmacology.PDF
·doi:10.3389/fphar.2024.1395160.s002

IntroductionEndometriosis (EMs) is characterized by ectopic growth of active endometrial tissue outside the uterus. The Luoshi Neiyi prescription (LSNYP) has been extensively used for treating EMs in China. However, data on the active chemi…

dataset 2024
DataSheet3_Potential mechanism of Luoshi Neiyi prescription in endometriosis based on serum pharmacochemistry and network pharmacology.PDF
·doi:10.3389/fphar.2024.1395160.s003

IntroductionEndometriosis (EMs) is characterized by ectopic growth of active endometrial tissue outside the uterus. The Luoshi Neiyi prescription (LSNYP) has been extensively used for treating EMs in China. However, data on the active chemi…

dataset 2024
DataSheet4_Potential mechanism of Luoshi Neiyi prescription in endometriosis based on serum pharmacochemistry and network pharmacology.PDF
·doi:10.3389/fphar.2024.1395160.s004

IntroductionEndometriosis (EMs) is characterized by ectopic growth of active endometrial tissue outside the uterus. The Luoshi Neiyi prescription (LSNYP) has been extensively used for treating EMs in China. However, data on the active chemi…

dataset 2024
DataSheet5_Potential mechanism of Luoshi Neiyi prescription in endometriosis based on serum pharmacochemistry and network pharmacology.PDF
·doi:10.3389/fphar.2024.1395160.s005

IntroductionEndometriosis (EMs) is characterized by ectopic growth of active endometrial tissue outside the uterus. The Luoshi Neiyi prescription (LSNYP) has been extensively used for treating EMs in China. However, data on the active chemi…

dataset 2024
DataSheet6_Potential mechanism of Luoshi Neiyi prescription in endometriosis based on serum pharmacochemistry and network pharmacology.PDF
·doi:10.3389/fphar.2024.1395160.s006

IntroductionEndometriosis (EMs) is characterized by ectopic growth of active endometrial tissue outside the uterus. The Luoshi Neiyi prescription (LSNYP) has been extensively used for treating EMs in China. However, data on the active chemi…

dataset 2024
Table1_Construction and evaluation of endometriosis diagnostic prediction model and immune infiltration based on efferocytosis-related genes.XLSX
·doi:10.3389/fmolb.2023.1298457.s001

Background: Endometriosis (EM) is a long-lasting inflammatory disease that is difficult to treat and prevent. Existing research indicates the significance of immune infiltration in the progression of EM. Efferocytosis has an important immun…